Company / Operating Cash Flow
Yubo International Biotech Ltd Operating Cash Flow History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$842.8K
FY2025
5-year range
-$1.3M / $101.1K
FY2021-FY2025
Trend
+37.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow returned to growth in FY2025 after 3 years of decline, reaching -$842,802.
Based on SEC 10-K filings.
-$842,802 in FY2025.
Declined from -$738,971 to -$842,802 over the past 2 years.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow increased 37.0% year-over-year.
- Peak operating cash flow was recorded in FY2020.
- Lowest operating cash flow in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -14.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$842.8K | +37.0% |
| FY2024 | -$1.3M | -81.0% |
| FY2023 | -$739.0K | -23.0% |
| FY2022 | -$601.0K | -694.4% |
| FY2020 | $101.1K | +416.0% |
| FY2019 | -$32.0K | +41.8% |
| FY2018 | -$55.0K | +0.0% |
| FY2017 | -$55.0K | +0.0% |
| FY2016 | -$55.0K | +1.8% |
| FY2015 | -$56.0K | -30.2% |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026